# Oragenics Inc: filings

OGEN · NYSE · CIK 1174940 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ogen.md) · [Financials](/companies/ogen/financials.md) · [Filings](/companies/ogen/filings.md) · [Insiders](/companies/ogen/insiders.md)

## Reports and events: 419 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 271, 4 262, 10-Q 53, CORRESP 24, SC 13D/A 24, UPLOAD 22, 424B5 20, 3 19, DEF 14A 19, 10-K 18, EFFECT 18, D 13, PRE 14A 12, SC 13G/A 12, DEFA14A 11, S-8 10, 424B3 9, S-1/A 9, SC 13G 9, 10-K/A 7, S-1 7, POS AM 6, S-3 6, 144 5, 4/A 5, 5 5, DEF 14C 5, PRE 14C 5, 8-K/A 4, CT ORDER 4, SC 13D 4, 10-Q/A 3, FWP 3, NT 10-K 3, RW 2, S-3/A 2, SCHEDULE 13G 2, 25-NSE 1, 424B4 1, 5/A 1, 8-A12B 1, ARS 1, CERTNYS 1, DRS 1, DRSLTR 1, NT 10-Q 1, S-1MEF 1, S-3MEF 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-16 | 04:30 ET | [8-K](/filings/0001493152-26-042843.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-042843 |
| 2026-08-28 | 13:06 ET | [8-K](/filings/0001493152-26-040645.md) | 3.01 Delisting notice; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-040645 |
| 2026-08-13 | 16:05 ET | [10-Q](/filings/0001493152-26-037749.md) | Quarterly report, period 2026-06-30 | 0001493152-26-037749 |
| 2026-07-06 | 16:05 ET | [8-K](/filings/0001493152-26-032155.md) | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-26-032155 |
| 2026-05-20 | 16:05 ET | [DEF 14A](/filings/0001493152-26-024602.md) | Proxy statement, period 2026-05-20 | 0001493152-26-024602 |
| 2026-05-19 | 08:38 ET | [8-K](/filings/0001493152-26-024363.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-024363 |
| 2026-05-08 | 16:01 ET | [10-Q](/filings/0001493152-26-021967.md) | Quarterly report, period 2026-03-31 | 0001493152-26-021967 |
| 2026-05-07 | 08:15 ET | [8-K](/filings/0001493152-26-021627.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-021627 |
| 2026-04-13 | 08:30 ET | [8-K](/filings/0001493152-26-016294.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-016294 |
| 2026-03-31 | 16:05 ET | [8-K](/filings/0001493152-26-014128.md) | 5.08 Item not in the standard list; 9.01 Financial statements and exhibits | 0001493152-26-014128 |
| 2026-03-16 | 16:30 ET | [10-K](/filings/0001493152-26-010282.md) | Annual report, period 2025-12-31 | 0001493152-26-010282 |
| 2026-03-11 | 16:26 ET | [8-K](/filings/0001493152-26-009682.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-009682 |
| 2026-01-22 | 16:05 ET | [8-K](/filings/0001493152-26-003237.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-26-003237 |
| 2026-01-20 | 08:30 ET | [8-K](/filings/0001493152-26-002759.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-002759 |
| 2025-12-15 | 16:05 ET | [8-K](/filings/0001493152-25-027745.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-25-027745 |
| 2025-11-12 | 08:15 ET | [8-K](/filings/0001493152-25-021749.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-021749 |
| 2025-11-07 | 16:06 ET | [10-Q](/filings/0001493152-25-021257.md) | Quarterly report, period 2025-09-30 | 0001493152-25-021257 |
| 2025-10-21 | 07:45 ET | [8-K](/filings/0001493152-25-018725.md) | 1.01 Entry into a material agreement; 3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-018725 |
| 2025-09-02 | 16:50 ET | [8-K](/filings/0001493152-25-012562.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-25-012562 |
| 2025-08-11 | 08:30 ET | [8-K](/filings/0001641172-25-022908.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-022908 |
| 2025-08-08 | 16:16 ET | [10-Q](/filings/0001641172-25-022766.md) | Quarterly report, period 2025-06-30 | 0001641172-25-022766 |
| 2025-07-02 | 16:30 ET | [8-K](/filings/0001641172-25-017575.md) | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-017575 |
| 2025-06-30 | 13:28 ET | [S-1/A](/filings/0001641172-25-017088.md) | Registration statement, amended | 0001641172-25-017088 |
| 2025-06-23 | 06:18 ET | [S-1](/filings/0001641172-25-015984.md) | Registration statement | 0001641172-25-015984 |
| 2025-05-28 | 07:00 ET | [8-K](/filings/0001641172-25-012596.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-012596 |
| 2025-05-20 | 17:10 ET | [8-K](/filings/0001641172-25-011774.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-011774 |
| 2025-05-09 | 16:30 ET | [10-Q](/filings/0001641172-25-009464.md) | Quarterly report, period 2025-03-31 | 0001641172-25-009464 |
| 2025-05-02 | 16:45 ET | [8-K](/filings/0001641172-25-008389.md) | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001641172-25-008389 |
| 2025-04-09 | 08:30 ET | [8-K](/filings/0001641172-25-003334.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-003334 |
| 2025-04-01 | 16:30 ET | [DEF 14A](/filings/0001641172-25-002090.md) | Proxy statement, period 2025-04-01 | 0001641172-25-002090 |
| 2025-03-27 | 08:30 ET | [8-K](/filings/0001641172-25-000855.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-000855 |
| 2025-03-14 | 16:30 ET | [10-K](/filings/0001493152-25-010389.md) | Annual report, period 2024-12-31 | 0001493152-25-010389 |
| 2025-03-06 | 09:15 ET | [8-K](/filings/0001493152-25-009335.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-009335 |
| 2025-02-18 | 16:30 ET | [8-K](/filings/0001493152-25-007182.md) | 5.08 Item not in the standard list; 9.01 Financial statements and exhibits | 0001493152-25-007182 |
| 2025-02-05 | 08:00 ET | [8-K](/filings/0001493152-25-004946.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-004946 |
| 2025-01-21 | 08:00 ET | [8-K](/filings/0001493152-25-002928.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-002928 |
| 2025-01-17 | 16:05 ET | [8-K](/filings/0001493152-25-002751.md) | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-002751 |
| 2025-01-08 | 06:06 ET | [S-1/A](/filings/0001493152-25-001268.md) | Registration statement, amended | 0001493152-25-001268 |
| 2024-12-31 | 11:47 ET | [S-1/A](/filings/0001493152-24-052623.md) | Registration statement, amended | 0001493152-24-052623 |
| 2024-12-18 | 10:00 ET | [S-1](/filings/0001493152-24-050649.md) | Registration statement | 0001493152-24-050649 |
| 2024-12-16 | 16:10 ET | [8-K](/filings/0001493152-24-050216.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-050216 |
| 2024-11-29 | 17:00 ET | [8-K](/filings/0001493152-24-048190.md) | 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001493152-24-048190 |
| 2024-11-13 | 14:40 ET | [10-Q](/filings/0001493152-24-045067.md) | Quarterly report, period 2024-09-30 | 0001493152-24-045067 |
| 2024-10-31 | 09:15 ET | [DEF 14A](/filings/0001493152-24-043144.md) | Proxy statement, period 2024-10-31 | 0001493152-24-043144 |
| 2024-10-18 | 08:30 ET | [8-K](/filings/0001493152-24-041500.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-041500 |
| 2024-10-16 | 10:30 ET | [8-K](/filings/0001493152-24-041255.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-041255 |
| 2024-10-15 | 18:25 ET | [8-K](/filings/0001493152-24-040974.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-24-040974 |
| 2024-10-09 | 07:30 ET | [8-K](/filings/0001493152-24-040523.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-040523 |
| 2024-09-20 | 16:11 ET | [8-K](/filings/0001493152-24-037602.md) | 5.02 Departure or appointment of officers or directors; 5.08 Item not in the standard list; 9.01 Financial statements and exhibits | 0001493152-24-037602 |
| 2024-09-05 | 16:45 ET | [8-K](/filings/0001493152-24-035166.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-035166 |

Page 1 of 9. [Older](/companies/ogen/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:06 ET. No prices; not investment advice.